NMDA Ab IgG by CBA-IFA, Serum with Reflex to Titer Build info

Synonyms

• N-METHYL-DA RECEPTOR AB IGG BY CBA-IFA, SERUM W
• NMDAIGG
• LAB10903

Short Name

N-METHYL-DA RECEPTOR AB IGG BY CBA-IFA, SERUM W

Procedure Master Number

LAB10903

Procedure ID

114304

Clinical Info

Anti-NMDA receptor IgG antibody is found in a subset of patients with autoimmune limbic encephalitis and may occur with or without associated tumor. Decreasing antibody levels may be associated with therapeutic response; therefore, clinical correlation must be strongly considered. A negative test result does not rule out a diagnosis of autoimmune limbic encephalitis.  

Specimen Type

Container

Gold Top Tube

Collection Instructions

Container/Tube: Gold top tube
Specimen: 1 mL serum ( 0.2 mL min)
Transport Temperature: Refrigerated.
 
Note: Separate serum from cells ASAP or within 2 hours of collection

Transport Instructions

Refrigerated.

Specimen Stability

Methodology

Semi-Quantitative Indirect Fluorescent Antibody
 
This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Days Performed

Tuesday and Friday

Performing Laboratory

ARUP Laboratories

CPT

86255; if reflexed, add 86256
 
Test performed Tuesday and Friday
TAT 2 - 6 Days

PDM

1559013

Results